S&P 500   4,571.05 (+0.03%)
DOW   36,086.29 (-0.33%)
QQQ   387.20 (+0.23%)
AAPL   193.93 (+2.38%)
MSFT   370.95 (+0.49%)
META   318.23 (-0.56%)
GOOGL   130.51 (+0.96%)
AMZN   147.79 (+2.04%)
TSLA   243.24 (+3.25%)
NVDA   463.01 (+1.74%)
NIO   7.61 (+3.96%)
BABA   72.34 (-0.94%)
AMD   117.50 (-0.90%)
T   17.11 (+2.70%)
F   10.59 (-1.03%)
MU   73.42 (-1.17%)
CGC   0.70 (-7.15%)
GE   120.41 (-0.92%)
DIS   91.17 (-0.91%)
AMC   7.23 (-3.47%)
PFE   29.49 (+0.72%)
PYPL   58.14 (-2.86%)
XOM   101.18 (-1.22%)
S&P 500   4,571.05 (+0.03%)
DOW   36,086.29 (-0.33%)
QQQ   387.20 (+0.23%)
AAPL   193.93 (+2.38%)
MSFT   370.95 (+0.49%)
META   318.23 (-0.56%)
GOOGL   130.51 (+0.96%)
AMZN   147.79 (+2.04%)
TSLA   243.24 (+3.25%)
NVDA   463.01 (+1.74%)
NIO   7.61 (+3.96%)
BABA   72.34 (-0.94%)
AMD   117.50 (-0.90%)
T   17.11 (+2.70%)
F   10.59 (-1.03%)
MU   73.42 (-1.17%)
CGC   0.70 (-7.15%)
GE   120.41 (-0.92%)
DIS   91.17 (-0.91%)
AMC   7.23 (-3.47%)
PFE   29.49 (+0.72%)
PYPL   58.14 (-2.86%)
XOM   101.18 (-1.22%)
S&P 500   4,571.05 (+0.03%)
DOW   36,086.29 (-0.33%)
QQQ   387.20 (+0.23%)
AAPL   193.93 (+2.38%)
MSFT   370.95 (+0.49%)
META   318.23 (-0.56%)
GOOGL   130.51 (+0.96%)
AMZN   147.79 (+2.04%)
TSLA   243.24 (+3.25%)
NVDA   463.01 (+1.74%)
NIO   7.61 (+3.96%)
BABA   72.34 (-0.94%)
AMD   117.50 (-0.90%)
T   17.11 (+2.70%)
F   10.59 (-1.03%)
MU   73.42 (-1.17%)
CGC   0.70 (-7.15%)
GE   120.41 (-0.92%)
DIS   91.17 (-0.91%)
AMC   7.23 (-3.47%)
PFE   29.49 (+0.72%)
PYPL   58.14 (-2.86%)
XOM   101.18 (-1.22%)
S&P 500   4,571.05 (+0.03%)
DOW   36,086.29 (-0.33%)
QQQ   387.20 (+0.23%)
AAPL   193.93 (+2.38%)
MSFT   370.95 (+0.49%)
META   318.23 (-0.56%)
GOOGL   130.51 (+0.96%)
AMZN   147.79 (+2.04%)
TSLA   243.24 (+3.25%)
NVDA   463.01 (+1.74%)
NIO   7.61 (+3.96%)
BABA   72.34 (-0.94%)
AMD   117.50 (-0.90%)
T   17.11 (+2.70%)
F   10.59 (-1.03%)
MU   73.42 (-1.17%)
CGC   0.70 (-7.15%)
GE   120.41 (-0.92%)
DIS   91.17 (-0.91%)
AMC   7.23 (-3.47%)
PFE   29.49 (+0.72%)
PYPL   58.14 (-2.86%)
XOM   101.18 (-1.22%)

Profound Medical (PRN) Price, Holdings, & News

C$14.28
-0.25 (-1.72%)
(As of 10:06 AM ET)
Today's Range
C$14.28
C$14.36
50-Day Range
C$11.20
C$15.07
52-Week Range
C$6.81
C$20.44
Volume
300 shs
Average Volume
12,170 shs
Market Capitalization
C$305.16 million
Assets Under Management
C$131.70 million
Dividend Yield
0.72%
Net Expense Ratio
0.60%
PRN stock logo

About Profound Medical (TSE:PRN)

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, palliative pain treatment of bone metastases, and osteoid osteoma. Profound Medical Corp. is headquartered in Mississauga, Canada.

PRN Stock Price History

PRN ETF News Headlines

Profound Medical Insider Ups Holding During Year
Countries Are Investing Heavily Into Securing Energy Independence
There's a worldwide "arms race" for countries to secure lithium - the critical metal essential to powering the world's green energy transition. While the U.S. is now investing heavily into lithium production, the North American supply chain has fallen far behind. One company is on a mission to change that and make a previously remote area the next great lithium mining hub.
Closing Bell: Profound Medical Corp up on Wednesday (PRN)
Closing Bell: Profound Medical Corp up on Thursday (PRN)
The Battery Metal Nobody Told You About
According to McKinsey and Company, the battery storage market is growing rapidly, especially with the transition to clean, renewable energy. Lithium-ion batteries still grab most of the headlines. But analysts now call safe and long-lasting batteries made with vanadium "the future of battery tech."
See More Headlines
Receive PRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Invesco
Fund Name
Invesco DWA Industrials Momentum ETF
Tax Classification
Regulated Investment Company
Inception Date
10/12/2006
Fund Manager
Peter Hubbard, Michael Jeanette, Tony Seisser, Jonathan Nixon

Fund Focus

Asset Class
Equity
Benchmark
DWA Industrials Technical Leaders Index
Category
Sector
Focus
Industrials
Development Level
Developed Markets
Region
North America
Number of Holdings
45

Fund Statistics

Assets Under Management
$131.70 million
Average Daily Volume
$18,993.80
Discount/Premium
-0.74%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Invesco Capital Management LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Invesco Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Susquehanna

Miscellaneous

Beta
1.14
Creation Unit
50,000
Creation Fee
$500.00
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Profound Medical Expenses

TypePRNIndustrials ETFsEquity ETFsTSE ETFsAll ETFs
Management Fee0.50%0.53%0.53%0.65%0.50%
Other Expenses0.14%0.37%0.53%0.14%0.57%
Total Expense0.64%0.68%0.69%0.72%0.69%
Fee Waiver-0.04%-0.69%-0.54%-0.04%-0.58%
Net Expense0.60%0.57%0.59%0.70%0.57%

Profound Medical (PRN) Holdings & Exposure

PRN Sector Exposure

PRN Industry Exposure

Key Executives

  • Dr. Arun Swarup Menawat MBA (Age 68)
    Ph.D., Chairman of the Board & CEO
    Comp: $748.72k
  • Mr. Rashed Dewan (Age 55)
    Chief Financial Officer
    Comp: $339.68k
  • Mr. Hartmut Warnken (Age 50)
    Chief Commercial Officer of Outside US
    Comp: $305.16k
  • Dr. Mathieu Burtnyk (Age 41)
    Senior Vice President of Product Leader TULSA-PRO
    Comp: $333.88k
  • Mr. Abbey Goodman (Age 40)
    Chief Commercial Officer of US
    Comp: $479.93k
  • Mr. Stephen Kilmer
    Investor Relations
  • Mr. Jacques F. Cornet (Age 67)
    Senior VP & Product Leader Sonalleve
  • Mr. Matthew Sobczyk C.A.
    CPA, Assistant Corporate Controller
  • Mr. Levant Tinaz
    Software Developer














PRN ETF - Frequently Asked Questions

How have PRN shares performed in 2023?

Profound Medical's stock was trading at C$0.95 at the start of the year. Since then, PRN shares have increased by 1,403.2% and is now trading at C$14.28.
View the best growth stocks for 2023 here
.

When is Profound Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 5th 2024.
View our PRN earnings forecast
.

How were Profound Medical's earnings last quarter?

Profound Medical Corp. (TSE:PRN) released its quarterly earnings data on Thursday, November, 2nd. The company reported ($0.35) earnings per share for the quarter, beating the consensus estimate of ($0.43) by $0.08. The business had revenue of $2.32 million for the quarter, compared to analyst estimates of $3.22 million.

What does PRN invest in?

Profound Medical is a equity fund issued by Invesco. PRN focuses on industrials investments and follows the DWA Industrials Technical Leaders Index. The fund's investments total to approximately $131.70 million assets under management.

What stocks does Profound Medical hold?
What is the management fee for Profound Medical?

Profound Medical's management fee is 0.50% and has other expenses of 0.14%. However, PRN has a fee waiver of -0.04% to reimburse the expenses. The net expense ratio for PRN is 0.60%.

What other stocks do shareholders of Profound Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Profound Medical investors own include Orocobre (ORL), Ballard Power Systems (BLDP), Whitecap Resources (WCP), Alcanna (CLIQ), Just Energy Group (JE), Kezar Life Sciences (KZR), Lithium Americas (LAC), Russel Metals (RUS) and Absolute Software Co. (ABT.TO) (ABT).

How do I buy shares of Profound Medical?

Shares of PRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:PRN) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -